Not all health systems own ambulatory pharmacies — two-thirds of the hospital systems UPMC contacted relied on external locations — but among the surveyed systems, retaining patients was the No. 1 reason for operating an ambulatory pharmacy.
The report defines ambulatory pharmacies as retail-style or walk-in pharmacies owned by hospitals or health systems. Inpatient pharmacy services are not included in this term.
In a question about the top challenges of running an ambulatory pharmacy, nearly every health system pharmacy leader answered differently. Only two responses saw duplicates: 340B program complexities and maintaining staffing levels.
“We are probably in a better place than a lot of retail organizations, but staffing is always an issue for us,” one respondent said. “If we lose one person, it takes six months to replace them.”
Other issues that cropped up were technology issues, market competition, space limitations and problems with integrating EHRs. One health system pharmacy executive said it was a struggle to prepare new pharmacies to gauge patient demands, including knowing which drugs to stock and creating relationships with drug suppliers.
While facing a myriad of setbacks, a majority of respondents said they’re investing in delivery services, refill reminders over text, integrating data into patient portals, and offering prescription refill requests through websites and apps. These were also the most popular projects for health systems to implement over the next two years.
Read the report here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.